HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Christine E Beattie Selected Research

Spinal Diseases (Disease, Spinal)

11/2017HuD and the Survival Motor Neuron Protein Interact in Motoneurons and Are Essential for Motoneuron Development, Function, and mRNA Regulation.
1/2015Motoneuron development influences dorsal root ganglia survival and Schwann cell development in a vertebrate model of spinal muscular atrophy.
7/2013Temporal requirement for SMN in motoneuron development.
4/2012Survival motor neuron affects plastin 3 protein levels leading to motor defects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Christine E Beattie Research Topics

Disease

14Spinal Muscular Atrophy (Progressive Muscular Atrophy)
01/2018 - 10/2006
6Glioblastoma (Glioblastoma Multiforme)
01/2022 - 02/2016
5Neoplasms (Cancer)
01/2020 - 02/2016
4Spinal Diseases (Disease, Spinal)
11/2017 - 04/2012
4Muscular Atrophy (Muscle Atrophy)
11/2017 - 04/2012
3Glioma (Gliomas)
01/2022 - 01/2017
3Seizures (Absence Seizure)
01/2017 - 08/2011
2Paralysis (Palsy)
07/2013 - 10/2009
1Ischemia
02/2017
1Gliosis
01/2017
1Brain Neoplasms (Brain Tumor)
02/2016
1Neurodegenerative Diseases (Neurodegenerative Disease)
12/2015
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
02/2013
1Proteostasis Deficiencies
02/2013
1Motor Neuron Disease (Primary Lateral Sclerosis)
10/2012
1Neuromuscular Diseases (Neuromuscular Disease)
06/2011
1Inborn Genetic Diseases (Disease, Hereditary)
10/2009
1Atrophy
10/2009
1Parkinson Disease (Parkinson's Disease)
04/2009

Drug/Important Bio-Agent (IBA)

15Proteins (Proteins, Gene)FDA Link
01/2022 - 10/2006
4plastinIBA
01/2015 - 04/2008
3Temozolomide (Temodar)FDA LinkGeneric
10/2017 - 02/2016
3Pentylenetetrazole (Metrazol)IBA
01/2017 - 08/2011
2Molecular Chaperones (Chaperone, Molecular)IBA
01/2022 - 10/2017
2(2,4- dihydroxy- 5- isopropylphenyl)- (5- (4- methylpiperazin- 1- ylmethyl)- 1,3- dihydroisoindol- 2- yl)methanoneIBA
01/2022 - 10/2017
2VimentinIBA
01/2017 - 02/2016
1Heat-Shock Proteins (Heat-Shock Protein)IBA
01/2022
1rebastinibIBA
01/2020
1RibonucleoproteinsIBA
01/2018
1epidermal growth factor receptor VIIIIBA
10/2017
1Complex MixturesIBA
01/2017
1Pharmaceutical PreparationsIBA
02/2016
1Glial Fibrillary Acidic ProteinIBA
02/2016
1Bortezomib (Velcade)FDA Link
02/2016
1Mutant Proteins (Protein, Mutant)IBA
02/2013
1Neuroprotective AgentsIBA
02/2013
1Anticonvulsants (Antiepileptic Drugs)IBA
01/2013
1KinesinsIBA
01/2013
1Microfilament Proteins (Actin Binding Proteins)IBA
04/2012
1Complement System Proteins (Complement)IBA
03/2011
1RNA (Ribonucleic Acid)IBA
04/2009
1Cholinergic Agents (Cholinergics)IBA
04/2009

Therapy/Procedure

4Therapeutics
01/2022 - 02/2016
2Drug Therapy (Chemotherapy)
01/2018 - 01/2017
1Aftercare (After-Treatment)
01/2017
1Muscle Denervation
07/2013
1Vagus Nerve Stimulation
01/2013
1Denervation
10/2009